nodes	percent_of_prediction	percent_of_DWPC	metapath
Iopamidol—Discomfort—Fludarabine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Iopamidol—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Iopamidol—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Iopamidol—Dyspnoea—Teniposide—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Iopamidol—Petechiae—Methotrexate—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Iopamidol—Confusional state—Fludarabine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Iopamidol—Neutropenia—Vincristine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Iopamidol—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Iopamidol—Infection—Fludarabine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Iopamidol—Decreased appetite—Teniposide—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Iopamidol—Renal failure—Carmustine—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Iopamidol—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Iopamidol—Vomiting—Mechlorethamine—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Iopamidol—Apnoea—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Iopamidol—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Iopamidol—Rash—Mechlorethamine—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Iopamidol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Iopamidol—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Iopamidol—Flushing—Bleomycin—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Iopamidol—Anorexia—Fludarabine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Iopamidol—Extravasation—Methotrexate—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Iopamidol—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Iopamidol—Myocardial infarction—Vincristine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Iopamidol—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Iopamidol—Feeling abnormal—Teniposide—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Iopamidol—Musculoskeletal stiffness—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Iopamidol—Chills—Bleomycin—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Iopamidol—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Iopamidol—Sweating—Vincristine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Iopamidol—Renal failure—Mitoxantrone—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Iopamidol—Nausea—Mechlorethamine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Iopamidol—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Iopamidol—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Iopamidol—Haemoglobin—Carmustine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Iopamidol—Urticaria—Teniposide—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Iopamidol—Oliguria—Methotrexate—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Iopamidol—Haemorrhage—Carmustine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Iopamidol—Abdominal pain—Teniposide—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Iopamidol—Body temperature increased—Teniposide—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Iopamidol—Paraesthesia—Fludarabine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Iopamidol—Hallucination—Carmustine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Iopamidol—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Iopamidol—Sweating—Mitoxantrone—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Iopamidol—Dyspnoea—Fludarabine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Iopamidol—Haematuria—Mitoxantrone—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Iopamidol—Dyspepsia—Fludarabine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Iopamidol—Decreased appetite—Fludarabine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Iopamidol—Visual impairment—Carmustine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Iopamidol—Fatigue—Fludarabine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Iopamidol—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Iopamidol—Hallucination—Vincristine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Iopamidol—Pain—Fludarabine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Iopamidol—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Iopamidol—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Iopamidol—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Iopamidol—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Iopamidol—Flushing—Carmustine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Iopamidol—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Iopamidol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Iopamidol—Asthenia—Teniposide—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Iopamidol—Malaise—Bleomycin—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Iopamidol—Pruritus—Teniposide—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Iopamidol—Arrhythmia—Carmustine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Iopamidol—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Iopamidol—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Iopamidol—Body temperature increased—Fludarabine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Iopamidol—Cough—Bleomycin—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Iopamidol—Diarrhoea—Teniposide—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Iopamidol—Chest pain—Bleomycin—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Iopamidol—Myalgia—Bleomycin—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Iopamidol—Coma—Methotrexate—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Iopamidol—Back pain—Carmustine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Iopamidol—Discomfort—Bleomycin—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Iopamidol—Chills—Mitoxantrone—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Iopamidol—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Iopamidol—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Iopamidol—Confusional state—Bleomycin—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Iopamidol—Tremor—Carmustine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Iopamidol—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Iopamidol—Infection—Bleomycin—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Iopamidol—Back pain—Vincristine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Iopamidol—Vomiting—Teniposide—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Iopamidol—Agitation—Carmustine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Iopamidol—Asthenia—Fludarabine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Iopamidol—Rash—Teniposide—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Iopamidol—Dermatitis—Teniposide—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Iopamidol—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Iopamidol—Headache—Teniposide—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Iopamidol—Pruritus—Fludarabine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Iopamidol—Back pain—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Iopamidol—Anorexia—Bleomycin—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Iopamidol—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Iopamidol—Agitation—Vincristine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Iopamidol—Hypotension—Bleomycin—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Iopamidol—Diarrhoea—Fludarabine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Iopamidol—Convulsion—Carmustine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Iopamidol—Hypertension—Carmustine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Iopamidol—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Iopamidol—Nausea—Teniposide—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Iopamidol—Chest pain—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Iopamidol—Myalgia—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Iopamidol—Anxiety—Carmustine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Iopamidol—Paraesthesia—Bleomycin—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Iopamidol—Malaise—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Iopamidol—Dyspnoea—Bleomycin—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Iopamidol—Convulsion—Vincristine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Iopamidol—Hypertension—Vincristine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Iopamidol—Confusional state—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Iopamidol—Decreased appetite—Bleomycin—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Iopamidol—Myalgia—Vincristine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Iopamidol—Visual disturbance—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Iopamidol—Cough—Mitoxantrone—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Iopamidol—Infection—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Iopamidol—Vomiting—Fludarabine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Iopamidol—Convulsion—Mitoxantrone—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Iopamidol—Rash—Fludarabine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Iopamidol—Dermatitis—Fludarabine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Iopamidol—Hypertension—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Iopamidol—Pain—Bleomycin—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Iopamidol—Headache—Fludarabine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Iopamidol—Tachycardia—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Iopamidol—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Iopamidol—Myalgia—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Iopamidol—Chest pain—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Iopamidol—Anxiety—Mitoxantrone—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Iopamidol—Discomfort—Mitoxantrone—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Iopamidol—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Iopamidol—Anorexia—Carmustine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Iopamidol—Infection—Vincristine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Iopamidol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Iopamidol—Confusional state—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Iopamidol—Hypotension—Carmustine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Iopamidol—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Iopamidol—Nausea—Fludarabine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Iopamidol—Infection—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Iopamidol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Iopamidol—Shock—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Iopamidol—Urticaria—Bleomycin—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Iopamidol—Anorexia—Vincristine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Iopamidol—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Iopamidol—Body temperature increased—Bleomycin—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Iopamidol—Irritability—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Iopamidol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Iopamidol—Paraesthesia—Carmustine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Iopamidol—Hypotension—Vincristine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Iopamidol—Dyspnoea—Carmustine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Iopamidol—Anorexia—Mitoxantrone—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Iopamidol—Ataxia—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Iopamidol—Decreased appetite—Carmustine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Iopamidol—Hypotension—Mitoxantrone—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Iopamidol—Paraesthesia—Vincristine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Iopamidol—Pain—Carmustine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Iopamidol—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Iopamidol—Decreased appetite—Vincristine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Iopamidol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Iopamidol—Feeling abnormal—Carmustine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Iopamidol—Fatigue—Vincristine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Iopamidol—Asthenia—Bleomycin—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Iopamidol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Iopamidol—Pain—Vincristine—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Iopamidol—Asthma—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Iopamidol—Pruritus—Bleomycin—lymphatic system cancer	0.001	0.001	CcSEcCtD
Iopamidol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000998	0.000998	CcSEcCtD
Iopamidol—Fatigue—Mitoxantrone—lymphatic system cancer	0.00099	0.00099	CcSEcCtD
Iopamidol—Pain—Mitoxantrone—lymphatic system cancer	0.000982	0.000982	CcSEcCtD
Iopamidol—Abdominal pain—Carmustine—lymphatic system cancer	0.000976	0.000976	CcSEcCtD
Iopamidol—Body temperature increased—Carmustine—lymphatic system cancer	0.000976	0.000976	CcSEcCtD
Iopamidol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000946	0.000946	CcSEcCtD
Iopamidol—Neutropenia—Methotrexate—lymphatic system cancer	0.000941	0.000941	CcSEcCtD
Iopamidol—Abdominal pain—Vincristine—lymphatic system cancer	0.000932	0.000932	CcSEcCtD
Iopamidol—Body temperature increased—Vincristine—lymphatic system cancer	0.000932	0.000932	CcSEcCtD
Iopamidol—Urticaria—Mitoxantrone—lymphatic system cancer	0.000912	0.000912	CcSEcCtD
Iopamidol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000908	0.000908	CcSEcCtD
Iopamidol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000908	0.000908	CcSEcCtD
Iopamidol—Vomiting—Bleomycin—lymphatic system cancer	0.0009	0.0009	CcSEcCtD
Iopamidol—Rash—Bleomycin—lymphatic system cancer	0.000892	0.000892	CcSEcCtD
Iopamidol—Dermatitis—Bleomycin—lymphatic system cancer	0.000891	0.000891	CcSEcCtD
Iopamidol—Asthenia—Carmustine—lymphatic system cancer	0.000886	0.000886	CcSEcCtD
Iopamidol—Renal failure—Methotrexate—lymphatic system cancer	0.000882	0.000882	CcSEcCtD
Iopamidol—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000872	0.000872	CcSEcCtD
Iopamidol—Sweating—Methotrexate—lymphatic system cancer	0.00086	0.00086	CcSEcCtD
Iopamidol—Haematuria—Methotrexate—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Iopamidol—Asthenia—Vincristine—lymphatic system cancer	0.000846	0.000846	CcSEcCtD
Iopamidol—Diarrhoea—Carmustine—lymphatic system cancer	0.000845	0.000845	CcSEcCtD
Iopamidol—Nausea—Bleomycin—lymphatic system cancer	0.00084	0.00084	CcSEcCtD
Iopamidol—Asthenia—Mitoxantrone—lymphatic system cancer	0.000824	0.000824	CcSEcCtD
Iopamidol—Dizziness—Carmustine—lymphatic system cancer	0.000817	0.000817	CcSEcCtD
Iopamidol—Haemoglobin—Methotrexate—lymphatic system cancer	0.000809	0.000809	CcSEcCtD
Iopamidol—Diarrhoea—Vincristine—lymphatic system cancer	0.000807	0.000807	CcSEcCtD
Iopamidol—Haemorrhage—Methotrexate—lymphatic system cancer	0.000805	0.000805	CcSEcCtD
Iopamidol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000786	0.000786	CcSEcCtD
Iopamidol—Vomiting—Carmustine—lymphatic system cancer	0.000785	0.000785	CcSEcCtD
Iopamidol—Dizziness—Vincristine—lymphatic system cancer	0.00078	0.00078	CcSEcCtD
Iopamidol—Rash—Carmustine—lymphatic system cancer	0.000779	0.000779	CcSEcCtD
Iopamidol—Dermatitis—Carmustine—lymphatic system cancer	0.000778	0.000778	CcSEcCtD
Iopamidol—Visual impairment—Methotrexate—lymphatic system cancer	0.000776	0.000776	CcSEcCtD
Iopamidol—Headache—Carmustine—lymphatic system cancer	0.000774	0.000774	CcSEcCtD
Iopamidol—Tinnitus—Methotrexate—lymphatic system cancer	0.000751	0.000751	CcSEcCtD
Iopamidol—Vomiting—Vincristine—lymphatic system cancer	0.00075	0.00075	CcSEcCtD
Iopamidol—Rash—Vincristine—lymphatic system cancer	0.000743	0.000743	CcSEcCtD
Iopamidol—Dermatitis—Vincristine—lymphatic system cancer	0.000743	0.000743	CcSEcCtD
Iopamidol—Headache—Vincristine—lymphatic system cancer	0.000739	0.000739	CcSEcCtD
Iopamidol—Nausea—Carmustine—lymphatic system cancer	0.000734	0.000734	CcSEcCtD
Iopamidol—Vomiting—Mitoxantrone—lymphatic system cancer	0.00073	0.00073	CcSEcCtD
Iopamidol—Rash—Mitoxantrone—lymphatic system cancer	0.000724	0.000724	CcSEcCtD
Iopamidol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000723	0.000723	CcSEcCtD
Iopamidol—Chills—Methotrexate—lymphatic system cancer	0.000723	0.000723	CcSEcCtD
Iopamidol—Headache—Mitoxantrone—lymphatic system cancer	0.000719	0.000719	CcSEcCtD
Iopamidol—Nausea—Vincristine—lymphatic system cancer	0.0007	0.0007	CcSEcCtD
Iopamidol—Dysgeusia—Methotrexate—lymphatic system cancer	0.000686	0.000686	CcSEcCtD
Iopamidol—Nausea—Mitoxantrone—lymphatic system cancer	0.000682	0.000682	CcSEcCtD
Iopamidol—Back pain—Methotrexate—lymphatic system cancer	0.000678	0.000678	CcSEcCtD
Iopamidol—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00065	0.00065	CcSEcCtD
Iopamidol—Malaise—Methotrexate—lymphatic system cancer	0.000632	0.000632	CcSEcCtD
Iopamidol—Cough—Methotrexate—lymphatic system cancer	0.000612	0.000612	CcSEcCtD
Iopamidol—Convulsion—Methotrexate—lymphatic system cancer	0.000607	0.000607	CcSEcCtD
Iopamidol—Chest pain—Methotrexate—lymphatic system cancer	0.000597	0.000597	CcSEcCtD
Iopamidol—Myalgia—Methotrexate—lymphatic system cancer	0.000597	0.000597	CcSEcCtD
Iopamidol—Discomfort—Methotrexate—lymphatic system cancer	0.00059	0.00059	CcSEcCtD
Iopamidol—Confusional state—Methotrexate—lymphatic system cancer	0.000577	0.000577	CcSEcCtD
Iopamidol—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000572	0.000572	CcSEcCtD
Iopamidol—Infection—Methotrexate—lymphatic system cancer	0.000568	0.000568	CcSEcCtD
Iopamidol—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000553	0.000553	CcSEcCtD
Iopamidol—Anorexia—Methotrexate—lymphatic system cancer	0.000545	0.000545	CcSEcCtD
Iopamidol—Hypotension—Methotrexate—lymphatic system cancer	0.000535	0.000535	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000521	0.000521	CcSEcCtD
Iopamidol—Paraesthesia—Methotrexate—lymphatic system cancer	0.000514	0.000514	CcSEcCtD
Iopamidol—Dyspnoea—Methotrexate—lymphatic system cancer	0.00051	0.00051	CcSEcCtD
Iopamidol—Dyspepsia—Methotrexate—lymphatic system cancer	0.000504	0.000504	CcSEcCtD
Iopamidol—Decreased appetite—Methotrexate—lymphatic system cancer	0.000497	0.000497	CcSEcCtD
Iopamidol—Fatigue—Methotrexate—lymphatic system cancer	0.000493	0.000493	CcSEcCtD
Iopamidol—Pain—Methotrexate—lymphatic system cancer	0.000489	0.000489	CcSEcCtD
Iopamidol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000471	0.000471	CcSEcCtD
Iopamidol—Urticaria—Methotrexate—lymphatic system cancer	0.000454	0.000454	CcSEcCtD
Iopamidol—Body temperature increased—Methotrexate—lymphatic system cancer	0.000452	0.000452	CcSEcCtD
Iopamidol—Abdominal pain—Methotrexate—lymphatic system cancer	0.000452	0.000452	CcSEcCtD
Iopamidol—Asthenia—Methotrexate—lymphatic system cancer	0.00041	0.00041	CcSEcCtD
Iopamidol—Pruritus—Methotrexate—lymphatic system cancer	0.000405	0.000405	CcSEcCtD
Iopamidol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000391	0.000391	CcSEcCtD
Iopamidol—Dizziness—Methotrexate—lymphatic system cancer	0.000378	0.000378	CcSEcCtD
Iopamidol—Vomiting—Methotrexate—lymphatic system cancer	0.000364	0.000364	CcSEcCtD
Iopamidol—Rash—Methotrexate—lymphatic system cancer	0.000361	0.000361	CcSEcCtD
Iopamidol—Dermatitis—Methotrexate—lymphatic system cancer	0.00036	0.00036	CcSEcCtD
Iopamidol—Headache—Methotrexate—lymphatic system cancer	0.000358	0.000358	CcSEcCtD
Iopamidol—Nausea—Methotrexate—lymphatic system cancer	0.00034	0.00034	CcSEcCtD
